Request a FREE Sample of our FcRn Binding Kit!Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CFD-H5256 | Human | Human Complement Factor D / CFD Protein, Fc Tag |
|
||
CFD-R5255 | Rhesus macaque | Rhesus macaque Complement Factor D / CFD Protein, Fc Tag |
|
||
CFD-R52H3 | Rhesus macaque / Cynomolgus | Rhesus macaque / Cynomolgus Complement Factor D / CFD Protein, His Tag (active enzyme) |
|
||
CFD-H52H8 | Human | Human Complement Factor D / CFD Protein, His Tag (active enzyme) |
|
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Danicopan | ACH-4471; ACH-0144471; ALXN-2040; ACH-CFDIS | Approved | Achillion Pharmaceuticals Inc | Voydeya, VOYDEYA | Japan | Hemoglobinuria, Paroxysmal | Alexion Pharmaceuticals Inc | 2024-01-18 | Hemoglobinuria, Paroxysmal; Coronavirus Disease 2019 (COVID-19); Glomerulonephritis, Membranoproliferative; Hepatic Insufficiency; Geographic Atrophy; Glomerulonephritis | Details |
Danicopan | ACH-4471; ACH-0144471; ALXN-2040; ACH-CFDIS | Approved | Achillion Pharmaceuticals Inc | Voydeya, VOYDEYA | Japan | Hemoglobinuria, Paroxysmal | Alexion Pharmaceuticals Inc | 2024-01-18 | Hemoglobinuria, Paroxysmal; Coronavirus Disease 2019 (COVID-19); Glomerulonephritis, Membranoproliferative; Hepatic Insufficiency; Geographic Atrophy; Glomerulonephritis | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Vemircopan | ACH-0145228; ACH-5228; ALXN-2050 | Phase 2 Clinical | Achillion Pharmaceuticals Inc | Myasthenia Gravis; Glomerulonephritis, IGA; Hemoglobinuria, Paroxysmal; Kidney Diseases; Lupus Nephritis; Hepatic Insufficiency | Details |
BCX-9930 | BCX-9930 | Phase 2 Clinical | Biocryst Pharmaceuticals Inc | Hemoglobinuria, Paroxysmal; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulonephritis | Details |
ACH-5548 | ACH-5548; ACH-0145548 | Phase 1 Clinical | Achillion Pharmaceuticals Inc | Autoimmune Diseases | Details |
BCX-10013 | BCX-10013 | Phase 1 Clinical | Biocryst Pharmaceuticals Inc | Hemoglobinuria, Paroxysmal | Details |
ALXN-2080 | ALXN-2080 | Phase 1 Clinical | Alexion Pharmaceuticals Inc | Details | |
Vemircopan | ACH-0145228; ACH-5228; ALXN-2050 | Phase 2 Clinical | Achillion Pharmaceuticals Inc | Myasthenia Gravis; Glomerulonephritis, IGA; Hemoglobinuria, Paroxysmal; Kidney Diseases; Lupus Nephritis; Hepatic Insufficiency | Details |
BCX-9930 | BCX-9930 | Phase 2 Clinical | Biocryst Pharmaceuticals Inc | Hemoglobinuria, Paroxysmal; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulonephritis | Details |
ACH-5548 | ACH-5548; ACH-0145548 | Phase 1 Clinical | Achillion Pharmaceuticals Inc | Autoimmune Diseases | Details |
BCX-10013 | BCX-10013 | Phase 1 Clinical | Biocryst Pharmaceuticals Inc | Hemoglobinuria, Paroxysmal | Details |
ALXN-2080 | ALXN-2080 | Phase 1 Clinical | Alexion Pharmaceuticals Inc | Details |
This web search service is supported by Google Inc.